RESUMEN
OBJECTIVE: To study whether genetic variation in coagulation and fibrinolysis genes contributes to cerebrovascular complications in bacterial meningitis. METHODS: We performed a nationwide prospective genetic association study in adult community-acquired bacterial meningitis patients. The exons and flanking regions of 16 candidate genes involved in coagulation and fibrinolysis pathways were sequenced. We analyzed whether genetic variation in these genes resulted in a higher risk of cerebrovascular complications, unfavorable outcome and differences in thrombocyte count on admission. RESULTS: From 2006 to 2011, a total of 1101 bacterial meningitis patients were identified of whom 622 supplied DNA for genotyping and passed genetic quality control steps. In 139 patients (22%) the episode of bacterial meningitis was complicated by cerebral infarction, and 188 (30%) had an unfavorable outcome. We identified the functional variant rs494860 in the protein Z (PROZ) gene as our strongest association with occurrence of cerebral infarction (odds ratio (OR) 0.49 (95% confidence interval 0.33-0.73), pâ¯=â¯5.2â¯×â¯10-4). After Bonferroni correction for multiple testing no genetic variant was significantly associated (p-value threshold 2.7â¯×â¯10-4). CONCLUSION: Our study suggests a functional genetic variation in the PROZ gene, rs494860, may be of importance in bacterial meningitis pathogenesis and cerebral infarction risk. Replication of this finding in other cohort studies populations is needed.
Asunto(s)
Coagulación Sanguínea/genética , Trastornos Cerebrovasculares/etiología , Fibrinólisis/genética , Estudios de Asociación Genética , Meningitis Bacterianas/complicaciones , Meningitis Neumocócica/complicaciones , Adulto , Anciano , Infarto Cerebral/epidemiología , Infarto Cerebral/etiología , Trastornos Cerebrovasculares/microbiología , Estudios de Cohortes , Infecciones Comunitarias Adquiridas/epidemiología , Infecciones Comunitarias Adquiridas/microbiología , Femenino , Variación Genética , Humanos , Masculino , Meningitis Bacterianas/epidemiología , Persona de Mediana Edad , Países Bajos/epidemiología , Oportunidad Relativa , Estudios Prospectivos , Análisis de Secuencia de ADNRESUMEN
OBJECTIVES: Listeria monocytogenes is a food-borne pathogen that can cause meningitis. The listerial genotype ST6 has been linked to increasing rates of unfavourable outcome over time. We investigated listerial genetic variation and the relation with clinical outcome in meningitis. METHODS: We sequenced 96 isolates from adults with listerial meningitis included in two prospective nationwide cohort studies by whole genome sequencing, and evaluated associations between bacterial genetic variation and clinical outcome. We validated these results by screening listerial genotypes of 445 cerebrospinal fluid and blood isolates from patients over a 30-year period from the Dutch national surveillance cohort. RESULTS: We identified a bacteriophage, phiLMST6 co-occurring with a novel plasmid, pLMST6, in ST6 isolates to be associated with unfavourable outcome in patients (p 2.83e-05). The plasmid carries a benzalkonium chloride tolerance gene, emrC, conferring decreased susceptibility to disinfectants used in the food-processing industry. Isolates harbouring emrC were growth inhibited at higher levels of benzalkonium chloride (median 60 mg/L versus 15 mg/L; p <0.001), and had higher MICs for amoxicillin and gentamicin compared with isolates without emrC (both p <0.001). Transformation of pLMST6 into naive strains led to benzalkonium chloride tolerance and higher MICs for gentamicin. CONCLUSIONS: These results show that a novel plasmid, carrying the efflux transporter emrC, is associated with increased incidence of ST6 listerial meningitis in the Netherlands. Suggesting increased disease severity, our findings warrant consideration of disinfectants used in the food-processing industry that select for resistance mechanisms and may, inadvertently, lead to increased risk of poor disease outcome.
Asunto(s)
Antiinfecciosos Locales/farmacología , Compuestos de Benzalconio/farmacología , Farmacorresistencia Bacteriana , Listeria monocytogenes/efectos de los fármacos , Listeria monocytogenes/genética , Meningitis por Listeria/microbiología , Meningitis por Listeria/mortalidad , Adulto , Anciano , Anciano de 80 o más Años , Antibacterianos/farmacología , Estudios de Cohortes , Femenino , Variación Genética , Genoma Bacteriano , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Listeria monocytogenes/aislamiento & purificación , Masculino , Persona de Mediana Edad , Países Bajos , Evaluación del Resultado de la Atención al Paciente , Filogenia , Plásmidos/genética , Polimorfismo de Nucleótido Simple , Vigilancia de la Población , Adulto JovenRESUMEN
BACKGROUND: Mortality and morbidity in patients with bacterial meningitis result from the proinflammatory response and dysregulation of coagulation and fibrinolysis. Thrombin-activatable fibrinolysis inhibitor (TAFI) is activated by free thrombin or thrombin in complex with thrombomodulin, and plays an antifibrinolytic role during fibrin clot degradation, but also has an anti-inflammatory role by inactivating proinflammatory mediators, such as complement activation products. OBJECTIVE: To assess the role of TAFI in pneumococcal meningitis. METHODS: We performed a prospective nationwide genetic association study in patients with bacterial meningitis, determined TAFI and complement levels in cerebrospinal fluid (CSF), and assessed the function of TAFI in a pneumococcal meningitis mouse model by using Cpb2 (TAFI) knockout mice. RESULTS: Polymorphisms (reference sequences: rs1926447 and rs3742264) in the CPB2 gene, coding for TAFI, were related to the development of systemic complications in patients with pneumococcal meningitis. Higher protein levels of TAFI in CSF were significantly associated with CSF complement levels (C3a, iC3b, and C5b-9) and with more systemic complications in patients with bacterial meningitis. The risk allele of rs1926447 (TT) was associated with higher levels of TAFI in CSF. In the murine model, consistent with the human data, Cpb2-deficient mice had decreased disease severity, as reflected by lower mortality, and attenuated cytokine levels and bacterial outgrowth in the systemic compartment during disease, without differences in the brain compartment, as compared with wild-type mice. CONCLUSIONS: These findings suggest that TAFI plays an important role during pneumococcal meningitis, which is likely to be mediated through inhibition of the complement system, and influences the occurrence of systemic complications and inflammation.
Asunto(s)
Carboxipeptidasa B2/fisiología , Meningitis Meningocócica/líquido cefalorraquídeo , Meningitis Neumocócica/líquido cefalorraquídeo , Polimorfismo de Nucleótido Simple , Adulto , Anciano , Animales , Daño Encefálico Crónico/etiología , Carboxipeptidasa B2/líquido cefalorraquídeo , Carboxipeptidasa B2/deficiencia , Carboxipeptidasa B2/genética , Hemorragia Cerebral/etiología , Infecciones Comunitarias Adquiridas/sangre , Infecciones Comunitarias Adquiridas/líquido cefalorraquídeo , Infecciones Comunitarias Adquiridas/complicaciones , Infecciones Comunitarias Adquiridas/genética , Complemento C3a/líquido cefalorraquídeo , Complemento C3b/líquido cefalorraquídeo , Complejo de Ataque a Membrana del Sistema Complemento/líquido cefalorraquídeo , Citocinas/sangre , Femenino , Fibrinólisis , Humanos , Masculino , Meningitis Meningocócica/sangre , Meningitis Meningocócica/complicaciones , Meningitis Meningocócica/genética , Meningitis Neumocócica/sangre , Meningitis Neumocócica/complicaciones , Meningitis Neumocócica/genética , Ratones , Ratones Endogámicos C57BL , Persona de Mediana Edad , Insuficiencia Respiratoria/etiología , Choque Séptico/etiología , Resultado del TratamientoRESUMEN
BACKGROUND: Pathogenic bacteria modulate the host coagulation system to evade immune responses or to facilitate dissemination through extravascular tissues. In particular, the important bacterial pathogens Salmonella enterica and Yersinia pestis intervene with the plasminogen/fibrinolytic system. Thrombin-activatable fibrinolysis inhibitor (TAFI) has anti-fibrinolytic properties as the active enzyme (TAFIa) removes C-terminal lysine residues from fibrin, thereby attenuating accelerated plasmin formation. RESULTS: Here, we demonstrate inactivation and cleavage of TAFI by homologous surface proteases, the omptins Pla of Y. pestis and PgtE of S. enterica. We show that omptin-expressing bacteria decrease TAFI activatability by thrombin-thrombomodulin and that the anti-fibrinolytic potential of TAFIa was reduced by recombinant Escherichia coli expressing Pla or PgtE. The functional impairment resulted from C-terminal cleavage of TAFI by the omptins. CONCLUSIONS: Our results indicate that TAFI is degraded directly by the omptins PgtE of S. enterica and Pla of Y. pestis. This may contribute to the ability of PgtE and Pla to damage tissue barriers, such as fibrin, and thereby to enhance spread of S. enterica and Y. pestis during infection.